• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Specialty Laboratories

Specialty Laboratories

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. UPDATE: Here's where a storm's a-comin' for investors, this global forecast says

    UPDATE: Here's where a storm's a-comin' for investors, this global forecast says

  2. UPDATE: Here's where a storm's a-comin' for investors, this global forecast says

    UPDATE: Here's where a storm's a-comin' for investors, this global forecast says

  3. UPDATE: Here's where a storm's a-comin' for investors, going by this global forecast

    UPDATE: Here's where a storm's a-comin' for investors, going by this global forecast

  4. UPDATE: YogaWorks IPO pulled on valuation concerns, not market conditions

    UPDATE: YogaWorks IPO pulled on valuation concerns, not market conditions

  5. Global Coronary Guidewires Market 2017-2021 with Abbott Vascular, Boston Scientific, Cordis, Medtronic & Terumo Medical Dominating - Research and Markets

    Global Coronary Guidewires Market 2017-2021 with Abbott Vascular, Boston Scientific, Cordis, Medtronic & Terumo Medical Dominating - Research and Markets

  6. Masimo Announces CE Marking of Noninvasive RPVi™, a rainbow® Multi-Wavelength Index of Pleth Variability

    Masimo Announces CE Marking of Noninvasive RPVi™, a rainbow® Multi-Wavelength Index of Pleth Variability

  7. Wall Street stocks poised to hold onto record run; ECB meeting in the spotlight

    Wall Street stocks poised to hold onto record run; ECB meeting in the spotlight

  8. MARKET SNAPSHOT: Stock Market Poised To Hold On To Record Run; ECB In The Spotlight

    MARKET SNAPSHOT: Stock Market Poised To Hold On To Record Run; ECB In The Spotlight

  9. UPDATE: Stock market poised to hold on to record run; ECB in the spotlight

    UPDATE: Stock market poised to hold on to record run; ECB in the spotlight

  10. YogaWorks IPO pulled on valuation concerns, not market conditions

    YogaWorks IPO pulled on valuation concerns, not market conditions

12345

©2017 Morningstar Advisor. All right reserved.